---
title: "Riociguat - Pulmonary Arterial Hypertension"
sidebar: mydoc_sidebar
permalink: db08931-mesh-d000081029-1.html
toc: false 
---


Path ID: `DB08931_MESH_D000081029_1`
{% include image.html url="images/db08931-mesh-d000081029-1.png" file="db08931-mesh-d000081029-1.png" alt="db08931-mesh-d000081029-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C542595 | riociguat | Drug |
| UniProt:P33402 | Guanylate cyclase soluble subunit alpha-2 | Protein |
| CHEBI:16356 | cyclic guanosine 3',5' monophosphate | ChemicalSubstance |
| GO:0038060 | nitric oxide-cGMP-mediated signaling pathway | BiologicalProcess |
| GO:0042311 | vasodilation | BiologicalProcess |
| GO:0060087 | vasular smooth muscle relaxation | BiologicalProcess |
| MESH:D000081029 | Pulmonary arterial hypertension | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Riociguat | INCREASES ACTIVITY OF | Guanylate Cyclase Soluble Subunit Alpha-2 |
| Guanylate Cyclase Soluble Subunit Alpha-2 | INCREASES ABUNDANCE OF | Cyclic Guanosine 3',5' Monophosphate |
| Cyclic Guanosine 3',5' Monophosphate | PARTICIPATES IN | Nitric Oxide-Cgmp-Mediated Signaling Pathway |
| Nitric Oxide-Cgmp-Mediated Signaling Pathway | CONTRIBUTES TO | Vasodilation |
| Vasodilation | CONTRIBUTES TO | Vasular Smooth Muscle Relaxation |
| Vasular Smooth Muscle Relaxation | PREVENTS | Pulmonary Arterial Hypertension |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08931](https://go.drugbank.com/drugs/DB08931)
  - [https://pubmed.ncbi.nlm.nih.gov/27263466/](https://pubmed.ncbi.nlm.nih.gov/27263466/)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218670/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218670/)
  - [https://pubmed.ncbi.nlm.nih.gov/19263460/](https://pubmed.ncbi.nlm.nih.gov/19263460/)
